US regulators sue ‘pharma bro’ Shkreli over drug monopoly

28-01-2020

Sarah Morgan

US regulators sue ‘pharma bro’ Shkreli over drug monopoly

Mark Van Scyoc / Shutterstock.com

The US Federal Trade Commission (FTC) and New York’s attorney general have sued incarcerated ‘pharma bro’ Martin Shkreli for allegedly monopolising the market for life-saving drug Daraprim (pyrimethamine).


Martin Shkreli, competition, antitrust, drug monopoly, Daraprim, Vyera Pharmaceuticals, Turing Pharmaceuticals, Letitia James, FTC

LSIPR